GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Iconic Labs ICON.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

1.38p

-13.75%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2025

Revenue

—

FY2015FY2025

Net income

−£628,200

FY2015FY2025

Free cash flow

−£448,100

FY2015FY2025

Shareholders' equity

−£4.0m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Revenue———£26,800£509,200£107,300—£50,800£25,000£50,600
Operating income−£555,100−£246,100−£1.6m−£762,100−£3.1m−£2.5m−£327,900−£2.8m−£1.2m−£275,400
Net income−£628,200−£246,100£4.6m−£762,100−£7.7m−£2.4m−£6.3m−£2.8m−£1.3m−£239,900
Diluted earnings per share-0.06-0.030.98-0.20-33,466.56-79,670.66-0.00-0.05-0.03-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Total assets£95,000£139,300£50,200—£401,600£360,700£38,600£1.4m£1.6m£131,100
Cash and short-term investments£35,700£129,300£50,200—£800£180,400£15,600£615,200£1.1m£33,800
Total liabilities£4.1m£3.5m£3.7m£8.9m£7.9m£3.5m£1.9m£2.0m£806,000£818,000
Debt£3.1m£2.6m£1.9m£2.4m£2.4m£1.7m£79,400£1.1m£413,700£714,500
Shareholders' equity−£4.0m−£3.4m−£3.6m−£8.9m−£7.5m−£3.1m−£1.8m−£568,800£823,700−£686,900
Shares outstanding11m9m5m4m0m—626m60m40m17m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Cash from operations−£448,100−£802,700−£919,800−£50,900£1.2m−£1.6m−£3.5m−£2.1m−£746,700−£213,200
Capital spending—————−£39,600−£7,500−£324,000−£205,500—
Free cash flow−£448,100−£802,700−£919,800−£50,900£1.2m−£1.6m−£3.5m−£2.5m−£952,200−£213,200

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2021Dec 2020
Revenue——————£13,100£496,100
Gross profit———————£496,100
Operating income−£293,800−£261,400−£516,200−£469,100−£898,200−£659,000−£2.2m−£946,200
Net income−£334,600−£293,700−£516,200£270,000−£920,000£5.5m−£6.8m−£915,700
Diluted earnings per share-0.03-0.03-0.070.03-0.1714,811.78-29,485.34-4,162.13
Total assets£95,000£85,200£139,300£10,000£50,000£92,900£401,600£1.9m
Cash and short-term investments£35,700£49,300£129,300£1,100£50,200£92,900£800£191,000
Debt£3.1m—£2.6m—————
Shareholders' equity−£4.0m−£3.7m−£3.4m−£2.7m−£3.6m−£3.5m−£7.5m−£1.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-10.0%-25.9%8.4%
Net income-6.2%-23.5%12.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2020FY2019FY2017FY2016
Price to earnings-0.5-0.80.0-3.4-57.7-85.8-291.0-428.8
Price to sales———95.7————

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10000-to-1 reverse split · 30 Aug 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.